107 related articles for article (PubMed ID: 24636244)
21. Current pharmaceutical design of antituberculosis drugs: future perspectives.
Speck-Planche A; Scotti MT; de Paulo-Emerenciano V
Curr Pharm Des; 2010; 16(24):2656-65. PubMed ID: 20642433
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistant tuberculosis: a continuing crisis.
Burki T
Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
[No Abstract] [Full Text] [Related]
23. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
Mokrousov I
Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
[No Abstract] [Full Text] [Related]
24. Is Shorter Treatment Regimen for Multidrug-resistant Tuberculosis feasible in Indian Children?
Shah I
Indian Pediatr; 2017 Feb; 54(2):160. PubMed ID: 28285296
[No Abstract] [Full Text] [Related]
25. Preclinical testing of new drugs for tuberculosis: current challenges.
Lenaerts AJ; Degroote MA; Orme IM
Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
[TBL] [Abstract][Full Text] [Related]
26. High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv.
Reynolds RC; Ananthan S; Faaleolea E; Hobrath JV; Kwong CD; Maddox C; Rasmussen L; Sosa MI; Thammasuvimol E; White EL; Zhang W; Secrist JA
Tuberculosis (Edinb); 2012 Jan; 92(1):72-83. PubMed ID: 21708485
[TBL] [Abstract][Full Text] [Related]
27. Mycobacterium tuberculosis drug resistance: a call to action.
Sudre P; Cohn DL
Int J Tuberc Lung Dis; 1998 Aug; 2(8):609-11. PubMed ID: 9712272
[No Abstract] [Full Text] [Related]
28. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ
J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Cole ST
Immunobiology; 1994 Oct; 191(4-5):584-5. PubMed ID: 7713574
[No Abstract] [Full Text] [Related]
30. Microbiology. TB--a new target, a new drug.
Cole ST; Alzari PM
Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
[No Abstract] [Full Text] [Related]
31. Update treatment of multidrug-resistant tuberculosis. Introduction, discussion and summary.
Youngchaiyud P; Iseman MD
Chemotherapy; 1999; 45 Suppl 2():1-2, 41-5. PubMed ID: 10523129
[No Abstract] [Full Text] [Related]
32. New treatment options for multidrug-resistant tuberculosis.
Field SK; Fisher D; Jarand JM; Cowie RL
Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
[TBL] [Abstract][Full Text] [Related]
33. Drug-resistant Mycobacterium tuberculosis, Taiwan.
Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
[No Abstract] [Full Text] [Related]
34. Mycobacterium tuberculosis "Beijing" epidemics: a race against mutations?
Bhatter P; Chatterjee A; Mistry N
Tuberculosis (Edinb); 2012 Jan; 92(1):92-4. PubMed ID: 22015174
[TBL] [Abstract][Full Text] [Related]
35. Identification of lipid metabolism-targeting compounds active against drug-resistant M. tuberculosis.
Singh AK; Karaulia P; Yadav P; Narender T; Singh SP; Sashidhara KV; Pandey AK; Chopra S; Dasgupta A
J Glob Antimicrob Resist; 2016 Dec; 7():26-27. PubMed ID: 27552738
[No Abstract] [Full Text] [Related]
36. Editorial commentary: pharmacokinetic variability and tuberculosis treatment outcomes, including acquired drug resistance.
Egelund EF; Peloquin CA
Clin Infect Dis; 2012 Jul; 55(2):178-9. PubMed ID: 22467672
[No Abstract] [Full Text] [Related]
37. Study of primary drug resistance of Mycobacterium tuberculosis from two hospitals in Tenerife, Canary Islands, Spain (1990-1997).
Lecuona M; Alvarez R; Quintero J; Torres A; Hernández AM; Montesinos I; Sierra A
Int J Tuberc Lung Dis; 2000 Feb; 4(2):186-7. PubMed ID: 10694101
[No Abstract] [Full Text] [Related]
38. Facing multi-drug resistant tuberculosis.
Sotgiu G; Migliori GB
Pulm Pharmacol Ther; 2015 Jun; 32():144-8. PubMed ID: 24792579
[TBL] [Abstract][Full Text] [Related]
39. New Griselimycins for Treatment of Tuberculosis.
Holzgrabe U
Chem Biol; 2015 Aug; 22(8):981-2. PubMed ID: 26295835
[TBL] [Abstract][Full Text] [Related]
40. Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital.
Arora J; Sidiq Z; Visalakshi P; Bhalla M; Behera D; Myneedu VP
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):380-1. PubMed ID: 24075630
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
